Top 10 Clinical Trends for August 2015

Ryan Syrek


August 21, 2015

#6 Clinical Trend: Entresto

Entresto, the new heart failure drug from Novartis, has been approved by the US Food and Drug Administration for patients with worsening heart failure. Some physicians are strongly advocating for early adoption of the drug. This term likely increased as a result of physicians trying to educate themselves on what they will recommend to their patients regarding this new pharmaceutical option.

For more in-depth clinical information, see Heart Failure.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.